Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Form 10-K Annual Report for Fiscal Year Ending HTML 984K
2015 December 31
2: EX-4.5 Common Stock Purchase Warrant Issued to Alexander HTML 89K
Capital, L.P.
3: EX-10.11 Form of Non-Qualified Stock Option Grant to HTML 50K
Non-Employee Directors
4: EX-10.12 Form of Non-Qualified Stock Option Grant for HTML 51K
Executive Officers
5: EX-10.13 Form of Non-Qualified Stock Option for Grants to HTML 52K
S. Kriegsman and Dr. D. Levitt
6: EX-10.14 Amendment No. 1 to Stock Option Agreements of Dr. HTML 34K
Daniel Levitt, Dated Dec. 31, 2015
7: EX-10.15 Amendment No. 1 to Stock Option Agreements (2000 HTML 34K
Plan) of Steven. Kriegsman, Dated March 8, 2016
8: EX-10.16 Amendment No. 1 to Stock Option Agreements (2008 HTML 35K
Plan) of Steven. Kriegsman, Dated March 8, 2016
9: EX-10.26 Dr. Daniel Levitt Employment Agreement Dated HTML 76K
December 31, 2015
10: EX-10.27 Benjamin Levin Employment Agreement Dated December HTML 55K
31, 2015
11: EX-10.28 Scott Wieland Employment Agreement Dated December HTML 58K
31, 2015
12: EX-10.29 John Caloz Employment Agreement Dated December 31, HTML 54K
2015
13: EX-10.30 Olivia Ware Employment Agreement Dated January 11, HTML 56K
2016
15: EX-10.36 Steven Kriegsman Third Amendment to 4th Amended HTML 28K
and Restated Employment Agreement Dated March 8,
2016
16: EX-23.1 Consent of Bdo Usa, LLP HTML 25K
17: EX-31.1 Certification of Chief Executive Officer, Pursuant HTML 30K
to 15 U.S.C. Section 7241
18: EX-31.2 Certification of Chief Financial Officer, Pursuant HTML 30K
to 15 U.S.C. Section 7241
14: EX-32 Letter Agreement With Alexander Capital LLP Dated HTML 47K
Feb. 9, 2016
19: EX-32.1 Certification of Chief Executive Officer, Pursuant HTML 25K
to 18 U.S.C. Section 1350
20: EX-32.2 Certification of Chief Financial Officer, Pursuant HTML 25K
to 18 U.S.C. Section 1350
27: R1 Document and Entity Information HTML 51K
28: R2 Balance Sheets HTML 90K
29: R3 Balance Sheets (Parenthetical) HTML 48K
30: R4 Statements of Operations HTML 65K
31: R5 Statements of Stockholders' Equity HTML 90K
32: R6 Statements of Cash Flows HTML 110K
33: R7 Nature of Business HTML 36K
34: R8 Summary of Significant Accounting Policies HTML 83K
35: R9 Foreign Currency Remeasurement HTML 30K
36: R10 Receivables HTML 28K
37: R11 Prepaid and Other Assets HTML 26K
38: R12 Short-term Investments HTML 30K
39: R13 Equipment and Furnishings HTML 35K
40: R14 Accrued Expenses and Other Current Liabilities HTML 35K
41: R15 Non-Cash litigation Settlement Due in Shares of HTML 27K
Common Stock
42: R16 Warrant Liabilities HTML 41K
43: R17 Commitments and Contingencies HTML 79K
44: R18 Equity Transactions HTML 37K
45: R19 Stock Options and Equity-Classified Warrants HTML 212K
46: R20 Stockholder Protection Rights Plan HTML 29K
47: R21 Income Taxes HTML 67K
48: R22 Quarterly Financial Data (Unaudited) HTML 53K
49: R23 Subsequent Event HTML 30K
50: R24 Schedule Ii - Valuation and Qualifying Accounts HTML 43K
51: R25 Summary of Significant Accounting Policies HTML 129K
(Policies)
52: R26 Summary of Significant Accounting Policies HTML 55K
(Tables)
53: R27 Equipment and Furnishings (Tables) HTML 33K
54: R28 Accrued Expenses and Other Current Liabilities HTML 35K
(Tables)
55: R29 Warrant Liabilities (Tables) HTML 39K
56: R30 Commitments and Contingencies (Tables) HTML 47K
57: R31 Stock Options and Equity-Classified Warrants HTML 212K
(Tables)
58: R32 Income Taxes (Tables) HTML 62K
59: R33 Quarterly Financial Data (Unaudited) (Tables) HTML 51K
60: R34 Nature of Business (Details) HTML 61K
61: R35 Summary of Significant Accounting Policies HTML 71K
(Details)
62: R36 Foreign Currency Remeasurement (Details) HTML 28K
63: R37 Receivables (Details) HTML 26K
64: R38 Prepaid and Other Assets (Details) HTML 26K
65: R39 Short-term Investments (Details) HTML 32K
66: R40 Equipment and Furnishings (Details) HTML 38K
67: R41 Accrued Expenses and Other Current Liabilities HTML 39K
(Details)
68: R42 Non-Cash litigation Settlement Due in Shares of HTML 40K
Common Stock (Details)
69: R43 Warrant Liabilities (Details) HTML 48K
70: R44 Commitments and Contingencies (Details) HTML 149K
71: R45 Equity Transactions (Details) HTML 53K
72: R46 Stock Options and Equity-Classified Warrants HTML 191K
(Details)
73: R47 Stock Options and Equity-Classified Warrants, HTML 90K
Options by Exercise Price Range (Details)
74: R48 Stock Options and Equity-Classified Warrants, HTML 77K
Warrants, Shares purchased and intrinsic value
(Details)
75: R49 Stockholder Protection Rights Plan (Details) HTML 36K
76: R50 Income Taxes (Details) HTML 112K
77: R51 Quarterly Financial Data (Unaudited) (Details) HTML 45K
78: R52 Subsequent Event (Details) HTML 41K
79: R53 Schedule Ii - Valuation and Qualifying Accounts HTML 36K
(Details)
81: XML IDEA XML File -- Filing Summary XML 116K
80: EXCEL IDEA Workbook of Financial Reports XLSX 72K
21: EX-101.INS XBRL Instance -- cytr-20151231 XML 1.91M
23: EX-101.CAL XBRL Calculations -- cytr-20151231_cal XML 186K
24: EX-101.DEF XBRL Definitions -- cytr-20151231_def XML 567K
25: EX-101.LAB XBRL Labels -- cytr-20151231_lab XML 1.55M
26: EX-101.PRE XBRL Presentations -- cytr-20151231_pre XML 958K
22: EX-101.SCH XBRL Schema -- cytr-20151231 XSD 152K
82: ZIP XBRL Zipped Folder -- 0000799698-16-000030-xbrl Zip 174K
‘EX-10.36’ — Steven Kriegsman Third Amendment to 4th Amended and Restated Employment Agreement Dated March 8, 2016
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
THIRD AMENDMENT TO FOURTH AMENDED
AND RESTATED EMPLOYMENT AGREEMENT
This Third Amendment (this "
Amendment") is entered into as of
March 8, 2016, between CytRx Corporation, a Delaware corporation ("
Employer"), and
Steven Kriegsman ("
Employee") in order to amend as follows that certain Fourth Amended and Restated Employment Agreement, effective as of
May 10, 2012, as amended by the First Amendment thereto dated as of
March 4, 2014 and the Second Amendment thereto dated as of
January 1, 2015 (as so amended, the "
Employment Agreement"), between Employer and Employee.
1. Stock Options. Section 6.3 of the Employment Agreement is hereby amended by removing therefrom the first sentence and substituting the following:
"Employer and Employee shall enter into mutually satisfactory amendments to all stock option agreements between Employer and Employee pursuant to Employer's 2008 Stock Incentive Plan to provide for the vesting, in full, of stock options subject to each such stock option agreement in the event of, and upon, FDA approval to market aldoxorubicin. Employee also shall be eligible for grants of stock options, restricted stock and other equity awards based on Employer stock in accordance with Employer's practices and policies with respect to its senior executives."
2. Survival. Section 20 of the Employment Agreement is hereby amended to add the following sentence at the end of current Section 20:
"For the avoidance of doubt and without limiting the foregoing, in the event of Employee's termination of employment by Employer other than for Cause or Employee's voluntary termination of employment with the Company for Good Reason, in either case following the expiration of the Term (including without limitation an expiration of the Term arising from the issuance of either party of non-renewal of this Agreement under Section 5), Employee shall be eligible for the severance benefits set forth in Sections 7.2, 7.3 and 7.5."
3. No Other Changes to the Employment Agreement. Except as expressly amended by this Amendment, all of the terms of the Employment Agreement shall remain in full force and effect.
IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first set forth above.
| EMPLOYER: |
|
|
EMPLOYEE: |
|
| CYTRX CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
